MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
NCT07478653 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-03-27
Summary
The goal of this clinical trial is to assess whether adjunctive dental cleaning can enhance the effects of semaglutide in children with obesity. The main question\[s\] it aims to answer \[is/are\]:
if dental cleaning will improve both oral health and metabolic outcomes beyond the effects of semaglutide alone.
Participants will receive either dental cleaning and oral hygiene instruction or oral hygiene instruction alone.
Conditions
- Obesity
- Dental Care for Children
Interventions
- PROCEDURE
-
Dental Cleaning and Oral Hygiene Instruction (OHI)
Participants receive dental cleaning and oral hygiene instruction (OHI) and oral health assessments at baseline (prior to initiating weight-loss medication), 6 months (±2 weeks), and 12 months (±1 month) post-enrollment.
- BEHAVIORAL
-
Oral Hygiene Instruction (OHI)
Participants will receive standard oral health care, including instructions on how to care for their teeth (OHI). Dental cleaning provided at 12 months.
Sponsors & Collaborators
-
Oelisoa Andriankaja
lead OTHER
Principal Investigators
-
Oelisoa Andriankaja, DDS, PhD · University of Kentucky
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-07-31
- Completion
- 2028-07-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
NCT06616961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth
NCT06934655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
NCT02692716 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation on Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of a Long-acting GLP-1 Analogue (Semaglutide) in an Oral Formulation in Healthy Male Subjects
NCT01866748 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
NCT05564117 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
NCT02696148 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
NCT02172313 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
NCT06215196 ·Status: COMPLETED ·Phase: NA
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity
NCT04263415 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
NCT04187300 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
NCT06737536 ·Status: COMPLETED ·Phase: PHASE1
-
Young Adults With Early-onset Obesity Treated With Semaglutide
NCT05574439 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
NCT06041217 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
NCT06422624 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Pharmacological Treatment - An Overview of Its Role in Managing Childhood Obesity
NCT07304141 ·Status: COMPLETED
-
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
NCT06478563 ·Status: COMPLETED ·Phase: PHASE1
-
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
NCT07411378 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
NCT05040971 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men
NCT03638778 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
NCT03021187 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
NCT02918279 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
NCT04469855 ·Status: COMPLETED
-
Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
NCT01572753 ·Status: COMPLETED ·Phase: PHASE1